Scientific Publications

Marinomed Biotech AG
News
Scientific Publications

Find here relevant scientific publications related to Marinomeds research as well as publications related to our research areas.

ALL
2022
2021
2020
2015

Iota-carrageenan extracted from red algae is a potent inhibitor of SARS‐CoV-2 infection in reconstituted human airway… (3 MB)

Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture (1 MB)

A randomized trial - intensive treatment based in Ivermectin and Iota-Carrageenan as pre-exposure prophylaxis for… (198 KB)

Virology Related

Hemilä et al., Pharmacology Research & Perspectives 2021; DOI: 10.1002/prp2.810

Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of… (759 KB)

Safety and efficacy of iota-carrageenan nasal spray in treatment and prevention of the common cold (395 KB)

Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model (530 KB)

Virology Related

M. Suchomel et. al; Austrian Society for Hygiene, Microbiology and Preventive Medicine

Use of gargle solutions and nasal sprays - two other allies in the defense against viral colds even in times of Covid-19… (188 KB)

Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel… (3 MB)

Virology Related

Schütz et al., American Journal of Physiology-Lung Cellular and Molecular Physiology, 2021

Carrageenan containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures (517 KB)

Nasal therapy — The missing link in optimising strategies to improve prevention and treatment of COVID-19 (355 KB)

Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta (2 MB)

PVP-I and Iota-Carrageenan Improve Subjective Clinical Symptoms In COVID-19 Emergency Hospital Wisma Atlet, Indonesia: A… (270 KB)

Natural Derived Nasal Spray; A Proposed Approach for COVID-19 Disease Control (527 KB)

Virology Related

Kramer et al., GMS Hygiene and Infection Control 2021, Vol. 16, ISSN 2196-5226

Virucidal gargling and virucidal nasal spray (157 KB)

Virology Related

Chen et al., International Journal of Biological Macromolecules, 2020, 164, 331-343

Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines (3 MB)

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 (3 MB)

Iota-carrageenan and Xylitol inhibit SARS-CoV-2 in cell culture (348 KB)

Virology Related

Hirsch et al., Journal of Infectious Diseases & Travel Medicine 2020, 4 (S1): 000S1-007

Covid 19 and Ivermectin Prevention and Treatment Update (229 KB)

Carrageenans as Broad-Spectrum Microbicides: Current Status and Challenges (664 KB)

The COVID 19 novel coronavirus pandemic 2020: seaweeds to the rescue? Why does substantial, supporting research about… (193 KB)

Virology Related

Carvallo et al., Journal of Biomedical Research and Clinical Investigation 2020; Volume 2 Isue 1.1007

Study of the Efficacy and Safety of Topical Ivermectin + Iota-Carrageenan in the Prophylaxis against COVID-19 in Health… (600 KB)

Iota-Carrageenan as an Antiviral Treatment for the Common Cold (3 MB)

Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the… (914 KB)

ALL
2020
2019

Saponin Micelles Lead to High Mucosal Permeation and In Vivo Efficacy of Solubilized Budesonide (1 MB)

Fast effectiveness of a solubilized low‐dose budesonide nasal spray in allergic rhinitis (1 MB)

Topical Pergolide Enhance Corneal Nerve Regrowth Following Induced Corneal Abrasion (2 MB)

Immunology Marinomed

Siegl et al., European Journal of Pharmaceutics and Biopharmaceutics 134, 2019, 88-95

Pharmacokinetics of topically applied tacrolimus dissolved in Marinosolv, a novel aqueous eye drop formulation (5 MB)

ALL
2014

Non-Invasive Optical Imaging of Eosinophilia during the Course of an Experimental Allergic Airways Disease Model and in… (3 MB)

Lucia Mayr-Harting, MSc

Public Relations

+ 43 2262 90300 pr@marinomed.com

Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com